Fisetin, sirtuin-activating compound (STAC)

Be the first to review this product! Submit a review

|

(0 Publication)

MW 286.24 Da, Purity >98%. Potent sirtuin-activating compound (STAC). Plant flavonol with various pharmacological effects. Anti-inflammatory, anticarcinogenic and antiviral activities..

View Alternative Names

12 LOX, 12(S) lipoxygenase, 12-lipoxygenase, 12LO, 12S-LOX, 12S-lipoxygenase, 12S-type, 15 LIPOXYGENASE RETICULOCYTE ARACHIDONATE, 15 LOX 1, 15 lipoxygenase 1, 15-LOX, A I, ACEE, ACES_HUMAN, ALOX15, ARACHE, ARG 1, ARGI1_HUMAN, Acetylcholinesterase, Al, Alox12, Apoptosis related acetylcholinesterase, Arachidonate 12 lipoxygenase, 12S type, Arachidonate 12-lipoxygenase, Arachidonate 12-oxidoreductase, Arachidonate 15-lipoxygenase, Arachidonate omega-6 lipoxygenase, Arginase liver, Arginase type I, Arginase-1, CCNB, CCNB1_HUMAN, CCNB2_HUMAN, CD5R1_HUMAN, CDC28A, CDK1_HUMAN, CDK5 activator 1, CDK5P35, CDK5R, CDK5R1, CDK5_HUMAN, CDK6_HUMAN, CDKN1, CELL CYCLE CONTROLLER CDC2, CK II, CK II alpha, CK II alpha', CK II beta, CK2A1, CK2A2, CK2B, CK2N, CSK21_HUMAN, CSK22_HUMAN, CSK2B_HUMAN, CSNK 2B, Casein kinase 2 alpha prime polypeptide, Casein kinase 2 beta polypeptide, Casein kinase II alpha chain, Casein kinase II alpha' chain, Casein kinase II beta subunit, Casein kinase II subunit alpha, Casein kinase II subunit alpha', Casein kinase II subunit beta, Casein kinase II, alpha 1 polypeptide, Casein kinase II, alpha 1 related sequence 4, Cdc 2, Cell Divsion Cycle 2 Protein, Cell division control protein 2, Cell division control protein 2 homolog, Cell division cycle 2 G1 to S and G2 to M, Cell division protein kinase 1, Cell division protein kinase 5, Cell division protein kinase 6, Crk 2, Crk6, Csnk2a1-rs4, CycB2, Cyclin B1, Cyclin B2, Cyclin-dependent kinase 1, Cyclin-dependent kinase 5, Cyclin-dependent kinase 5 activator 1, Cyclin-dependent kinase 5 regulatory subunit 1, Cyclin-dependent kinase 6, DINB protein, DINB1, DINP, DKFZp686D0638, DKFZp686L20222, DNA damage inducible protein b, DNA polymerase kappa, DinB homolog 1 (E. coli), FLJ43934, G2 mitotic specific cyclin B1, G2 mitotic specific cyclin B2, G2/mitotic specific cyclin B3, G2/mitotic-specific cyclin-B1, G2/mitotic-specific cyclin-B2, G5A, GSK-3 alpha, GSK-3 beta, GSK3A_HUMAN, GSK3B_HUMAN, GSK3beta isoform, Glycogen synthase kinase-3 alpha, Glycogen synthase kinase-3 beta, HsT17299, LOG12, LOG15, LOX12_HUMAN, LOX15_HUMAN, Lipoxin synthase 12-LO, Liver-type arginase, MCPH12, MGC102141, MGC108931, MGC111195, MGC138222, MGC138224, MGC140694, MGC59692, N-ACHE, NCK 5A, Neuronal CDK5 activator, OTTMUSP00000016898;, Oncogene PIM 1, P-12LO, P23, P34CDC2, P35, PIM, PIM1_HUMAN, PLSTIRE, POLK_HUMAN, POLQ, PSSALRE, Phosvitin, Pim 1 kinase, Pim 1 oncogene, Platelet 12-LOX, Platelet-type lipoxygenase 12, Polymerase (DNA directed) kappa, Protein G5a, Protein kinase CDK5 splicing, Proto-oncogene serine/threonine-protein kinase Pim-1, Proviral integration site 1, Proviral integration site 2, RP11 805H4.3, RP23-452D3.3, Regulatory partner for CDK5 kinase, STQTL11, Serine threonine protein kinase PSSALRE, Serine/threonine protein kinase GSK3A, Serine/threonine-protein kinase GSK3B, Serine/threonine-protein kinase PLSTIRE, Serine/threonine-protein kinase PSSALRE, TPKII catalytic subunit, TPKII regulatory subunit, Tau protein kinase II 23 kDa subunit, Tau protein kinase II catalytic subunit, Type I arginase, YT, YT blood group, p25, p34 Cdk1, p34 protein kinase, pim 1 kinase 44 kDa isoform, pim 1 oncogene (proviral integration site 1), platelet-type 12-lipoxygenase, polymerase, DNA, kappa